Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Ovarian cancer stem cells (OCSC) are responsible for cancer initiation, recurrence, therapeutic resistance, and metastasis. The OCSC vascular niche is considered to promote self-renewal of OCSCs, leading to chemoresistance. This protocol provides the basis for establishing a reproducible OCSC vascular niche model in vitro.

Abstract

Cancer stem cells (CSCs) reside in a supportive niche, constituting a microenvironment comprised of adjacent stromal cells, vessels, and extracellular matrix. The ability of CSCs to participate in the development of endothelium constitutes an important characteristic that directly contributes to the general understanding of the mechanisms of tumorigenesis and tumor metastasis. The purpose of this work is to establish a reproducible methodology to investigate the tumor-initiation capability of ovarian cancer stem cells (OCSCs). Herein, we examined the neovascularization mechanism between endothelial cells and OCSCs along with the morphological changes of endothelial cells using the in vitro co-culture model NICO-1. This protocol allows visualization of the neovascularization step surrounding the OCSCs in a time course manner. The technique can provide insight regarding the angiogenetic properties of OCSCs in tumor metastasis.

Introduction

Ovarian cancer is the eighth most common malignancy in women worldwide, with approximately 300,000 new diagnoses and an estimated 180,000 deaths annually1. At initial diagnosis, ovarian cancer often presents with severe symptoms, with about 75% of patients already at stage III-IV. Accordingly, the 5-year survival rate is <30% and the mortality rate is the highest among gynecological cancers2, with the efficiency of treatment for ovarian cancer being highly dependent on clinical factors such as the successful accomplishment of debulking surgery, resistance to chemotherapy, and recurrence after the initial therapy.

....

Protocol

All procedures were performed under the protocol approved by the Ethics Committee for human welfare. All patients provided written informed consent for the research use of their samples, and the collection and use of tissues for this study were approved by the Human Genome, Gene Analysis Research Ethics Committee at Teikyo University.

1. Isolation and culture of ovarian cancer stem cells (OCSCs) from Patients with ovarian cancer and ascites in a level 2 biosafety cabinet

  1. Isolate ca.......

Representative Results

We collected ascites fluids obtained from patients with advanced ovarian cancer during surgery or paracentesis for the purpose of performing a long-term stable culture for spheroids. Here, we present cases of a long-term spheroid culture of ovarian CSCs termed CSC1 and CSC2. Both cell lines carry the same diagnosis and histological profiles. The mechanistic roles of OCSCs underlying the interaction with endothelial cells necessary to induce the neovascularization of endothelial cells surr.......

Discussion

The presented protocol describes how to mimic the tumor microenvironment of OCSCs in an in vitro setting. The primary component of the method constitutes the highly reproducible coculture model obtained using the NICO-1 system, an indirect Transwell co-culture system. Many of the currently available coculture models examine the effects of direct cell-cell contact on cocultured cell populations12,13,14,

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work was supported by a Grant-in-Aid for Scientific Research C (grant no. 19K09834 to K.N.) from the Ministry of Education, Science, and Culture, Japan.

....

Materials

NameCompanyCatalog NumberComments
0.025% Trypsin ThermoR001100
10 mL PipetThermo170356N
1250 µL Pipet tipQSPT112XLRS-Q
15 mL tubeNunc339650
200 µL Pipet tipQSPT110RS-NEW
2-MercaptoethanolThermo (Gibco)21985023
5 mL PipetThermo170366N
50 mL tubeCorning430290
AccuMAXInnovative Cell TechnologiesAM105
BioCoatTM Collagen I 60mm DishCorning356401
CentrifugeKUBOTA2800
Costar 6 Well Clear Flat Bottom Ultra Low Attachment Multiple Well PlatesCorning3471
Endothelial Cell Growth Medium 2 PromoCellC-22011 
EthanolWAKO057-00456
FGF-BasicThermo (Gibco)PHG0021
HistodenzSIGMAD2158
HUEhT-1 cellJCRB Cell BankJCRB1458
ICCP Filter 0.6 µmGinrei Lab.2525-06
Insulin, humanSIGMA (Roche)11376497001
LuminometerPerkinElmerARVO MX-flad
Matrigel MatrixCorning356234
MicroscopeYokogawaCQ-1
NICO-1Ginrei Lab.2501-02
OptiPlate-96PerkinElmer6005290
P1000 PipetGilsonF123602
P200 PipetGilsonF123601
PBSThermo (Gibco)14190-144
StemPro hESC SFMThermo (Gibco)A1000701
Transfer PipetFALCON357575
Y-27632WAKO253-00513

References

  1. Bray, F., et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA, a Cancer Journal for Clinicians. 68, 394-424 (2018).
  2. Lengyel, E.

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Ovarian CancerCancer Stem CellsAngiogenesis3D Co culture SystemNICO 1Density Gradient CentrifugationOCSC MediumHUEhT 1 Endothelial CellsTumor MicroenvironmentParacentesisCell Detachment

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved